BEAT

BioTelemetry Stock Price

71.96
0.00 (0.0%)
71.96
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
BioTelemetry Inc BEAT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 71.96 19:00:00
Open Price Low Price High Price Close Price Prev Close
71.96 71.96
Bid Price Ask Price Spread News
72.50 71.99 -0.51 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 71.96 USD

BioTelemetry Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.47B 34.31M 21.57M $ 439.11M $ 21.65M 0.82 153.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

BioTelemetry News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BEAT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month71.6772.0071.6771.91841,0140.290.4%
3 Months58.6573.1057.4271.531,087,99113.3122.69%
6 Months39.3673.1035.7563.02622,23032.6082.83%
1 Year43.3473.1027.3554.53473,92428.6266.04%
3 Years32.5080.9227.3554.20434,41539.46121.42%
5 Years12.2080.9210.9643.65418,79259.76489.84%

BioTelemetry Description

BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. It operates under healthcare, technology, and research segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials and the Technology segment, focuses on the development, manufacturing, testing, and marketing of cardiovascular and blood glucose monitoring devices to medical companies, clinics and hospitals.


Your Recent History
NASDAQ
BEAT
BioTelemet..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.